These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18506408)

  • 1. [Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department].
    Dietrich T; Weisbach V; Seitz B; Jacobi C; Kruse FE; Eckstein R; Cursiefen C
    Ophthalmologe; 2008 Nov; 105(11):1036-8, 1040-2. PubMed ID: 18506408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].
    Kasper K; Godenschweger L; Hartwig D; Unterlauft JD; Seitz B; Geerling G
    Ophthalmologe; 2008 Jul; 105(7):644-9. PubMed ID: 18612645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?].
    Geerling G; Grus F; Seitz B; Hartwig D; Schirra F
    Ophthalmologe; 2008 Jul; 105(7):632-8. PubMed ID: 18587585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous serum and alternative blood products for the treatment of ocular surface disorders].
    Geerling G; Unterlauft JD; Kasper K; Schrader S; Opitz A; Hartwig D
    Ophthalmologe; 2008 Jul; 105(7):623-31. PubMed ID: 18607606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Albumin eye drops for treatment of ocular surface diseases].
    Unterlauft JD; Kohlhaas M; Hofbauer I; Kasper K; Geerling G
    Ophthalmologe; 2009 Oct; 106(10):932-7. PubMed ID: 19813016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum eye drop preparation in Australia: Current manufacturing practice.
    Marks DC; Fisher J; Mondy P; Segatchian J; Dennington PM
    Transfus Apher Sci; 2015 Aug; 53(1):92-4. PubMed ID: 26123029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [AUTOLOGOUS SERUM AS A TREATMENT FOR THE OCULAR SURFACE DISEASE].
    Hayat H; Masarwa D
    Harefuah; 2023 Mar; 162(3):187-188. PubMed ID: 37012680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 100% autologous serum drops in ocular surface disorders.
    Jover Botella A; Márquez Peiró JF; Márques K; Monts Cambero N; Selva Otaolaurruchi J
    Farm Hosp; 2011; 35(1):8-13. PubMed ID: 20619713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of standardized guidelines for the production and quality control of autologous serum eye drops in Korea: based on a nationwide survey.
    Lee HR; Hong YJ; Chung S; Hwang SM; Kim TS; Song EY; Park KU; Song J; Han KS
    Transfusion; 2014 Jul; 54(7):1864-70. PubMed ID: 24617756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects].
    Sauer R; Blüthner K; Seitz B
    Ophthalmologe; 2004 Jul; 101(7):705-9. PubMed ID: 14999414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies.
    Gabriel C; Marks DC; Henschler R; Schallmoser K; Burnouf T; Koh MBC
    Vox Sang; 2023 Apr; 118(4):301-309. PubMed ID: 36847186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology.
    Shtein RM; Shen JF; Kuo AN; Hammersmith KM; Li JY; Weikert MP
    Ophthalmology; 2020 Jan; 127(1):128-133. PubMed ID: 31561880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous serum for ocular surface diseases.
    Quinto GG; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum drops for ocular surface disease: national survey of Canadian cornea specialists.
    Marchand M; Harissi-Dagher M; Germain M; Thompson P; Robert MC
    Can J Ophthalmol; 2018 Jun; 53(3):266-271. PubMed ID: 29784164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations.
    Espinosa A; Hjorth-Hansen H; Aasly K; Teigum I; Sivertsen G; Seghatchian J
    Transfus Apher Sci; 2015 Aug; 53(1):88-91. PubMed ID: 26027793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous and allogeneic serum eye drops. The Dutch perspective.
    van der Meer PF; Seghatchian J; de Korte D
    Transfus Apher Sci; 2015 Aug; 53(1):99-100. PubMed ID: 26138910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.